Sign In
Buy DTIL
$6.04
-0.280 (-4.43%)
At Close: Jun 03, 2026
Wrapbook Funding Accelerates First All-in-One Payroll, Compliance and Insurance Platform for Entertainment Industry
12:00am, Tuesday, 25'th Aug 2020
Wrapbook which powers payroll, insurance, and compliance for the entertainment industry today announces $3.6M in Seed funding for its software platfor
DURHAM, N.C., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® ge
Precision BioSciences (DTIL) Reports Q2 Loss, Misses Revenue Estimates
02:35pm, Thursday, 13'th Aug 2020
Precision BioSciences (DTIL) delivered earnings and revenue surprises of -5.00% and -80.81%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Precision BioSciences: Q2 Earnings Insights
11:30am, Thursday, 13'th Aug 2020
Shares of Precision BioSciences (NASDAQ:DTIL) were unchanged after the company reported Q2 results.Quarterly Results Earnings per share decreased 61.54% year over year to ($0.63), which missed the est
Precision BioSciences Reports Second Quarter 2020 Financial Results and Provides Business Update
11:00am, Thursday, 13'th Aug 2020
Dosed First Patient in Phase 1/2a Clinical Trial of PBCAR269A, a BCMA-Targeted Allogeneic CAR T Candidate for Multiple Myeloma PBCAR0191 and PBCAR20A Clinical Studies Progressing; Updated Interim Dat
Fenomena awan layaknya tsunami di Aceh akibat dinamika atmosfer
12:15am, Tuesday, 11'th Aug 2020
Deputi bidang Meteorologi Badan Meteorologi Klimatologi dan Geofisika (BMKG) Guswanto mengatakan fenomena awan hitam memanjang yang terjadi di Meulaboh ...
Arcus Biosciences Announces New Employment Inducement Grants
12:00am, Tuesday, 11'th Aug 2020
Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced t
Earnings Preview: Precision BioSciences (DTIL) Q2 Earnings Expected to Decline
04:30pm, Thursday, 06'th Aug 2020
Precision BioSciences (DTIL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates
12:00am, Thursday, 06'th Aug 2020
Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced f
Acorda Reports Second Quarter 2020 Financial Results
12:00am, Tuesday, 04'th Aug 2020
Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the second quarter ended June 30, 202
Precision BioSciences to Report Second Quarter 2020 Financial Results and Present at Upcoming Investor Conferences
11:00am, Monday, 03'rd Aug 2020
DURHAM, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® ge
Will Precision BioSciences (NASDAQ:DTIL) Spend Its Cash Wisely?
02:29pm, Friday, 17'th Jul 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Head to Head Review: Precision BioSciences (NASDAQ:DTIL) versus Idera Pharmaceuticals (NASDAQ:IDRA)
01:28am, Tuesday, 14'th Jul 2020
Precision BioSciences (NASDAQ:DTIL) and Idera Pharmaceuticals (NASDAQ:IDRA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the stren
